Table 2.
Schedule for outcome measurement
| Outcome | Measurement | Baseline phase | Intervention phase | Follow-up phase | ||||
| Day 28 of first line chemotherapy | Day 42 of first line chemotherapy | Day 28 of first line chemotherapy | Day 42 of first line chemotherapy | 3, 6, 12, 24, 36 months after | After postmortem of the patient | |||
| Patient in baseline phase | Patient’s communication behaviour | RIAS | 〇 | |||||
| Patient’s medical and sociological background | Cancer stage, diagnosis date, treatment status, treatment history, comorbidities, sex, age, work status, household income, household size, social support, marital status, educational experience, treatment and care preference at the end of life | 〇 | ||||||
| Patient’s evaluation of consultation | ‘How did the oncologist respond to your questions?’ ‘Did you ask selected questions during consultation?’ ‘How much have you discussed with the oncologist in the visit?’ | 〇 | ||||||
| Patient in intervention and follow-up phase | Patient’s communication behaviour | RIAS | 〇 | |||||
| Patient’s psychological distress | HADS | 〇 | 〇 | 〇 | ||||
| Patient’s physical and functional QoL | FACT-Physical and Functional | 〇 | 〇 | 〇 | ||||
| Patient’s comprehensive QoL | Short version of CoQoLo | 〇 | 〇 | 〇 | ||||
| Patient’s trust in oncologist | TiOS | 〇 | 〇 | 〇 | ||||
| Patient’s satisfaction with oncologist | CSQ | 〇 | 〇 | 〇 | ||||
| Patient’s acceptance in cancer experience | PEACE | 〇 | 〇 | 〇 | ||||
| Patient’s prognosis and treatment perception | PTPQ | 〇 | 〇 | 〇 | ||||
| Patient’s evaluation of consultation | ‘How did the oncologist respond to your questions?’ ‘Did you ask selected questions during consultation?’ ‘How much have you discussed with the oncologist in the visit?’ | 〇 | ||||||
| Patient’s evaluation of intervention in the IG | ‘Did you understand how to use the QPL and did you actually use it?’ ‘Do you think you will continue the intervention?’ ‘Was the intervention useful to you?’ ‘Did the oncologist talk about the QPL?’ ‘Did the QPL help you ask the oncologist questions?’ ‘Is the QPL useful?’ ‘Did you read the QPL before the visit?’ ‘Do you think you will read the QPL in the future?’ | 〇 | ||||||
| Patient’s medical and sociological background | Cancer stage, diagnosis date, treatment status, treatment history, comorbidities, sex, age, job status, household income, household size, social support, marital status, educational experience, treatment and care preference at the end of life | 〇 | ||||||
| Patient’s medical utilisation at the end of life | The date of death, any chemotherapy agent given within 14 days of death, any new chemotherapeutic regimen started within 30 days of death, and involvement of hospice and palliative care services | 〇 | ||||||
| Caregiver in baseline phase | Caregiver’s communication behaviour | RIAS | 〇 | |||||
| Caregiver’s characteristics | Sex, age, relationship with the patient, job status, household income, household size, social support, marital status, educational experience, and preferences on treatment and care for the patient at the end of life | 〇 | ||||||
| Caregiver’s evaluation of consultation | ‘How did the oncologist respond to your questions?’ ‘Did you ask selected questions during consultation?’ ‘How much have you discussed with your oncologist in the visit?’ | 〇 | ||||||
| Caregiver in intervention and follow-up phase | Caregiver’s communication behaviour | RIAS | 〇 | |||||
| Caregiver’s psychological distress | K6 | 〇 | 〇 | 〇 | 〇 | |||
| Caregiver’s QoL | EQ-5D | 〇 | 〇 | 〇 | 〇 | |||
| Caregiver’s satisfaction with oncologist | CSQ | 〇 | 〇 | 〇 | ||||
| Caregiver’s sociological background | Sex, age, relationship with the patient, job status, household income, household size, social support, marital status, educational experience, and preferences on treatment and care for the patient at the end of life | |||||||
| Caregiver’s prognosis and treatment perception | PTPQ | 〇 | 〇 | 〇 | ||||
| Caregiver’s evaluation of consultation | ‘How did the oncologist respond to your questions?’ ‘Did you ask selected questions during consultation?’ ‘How much have you discussed with the oncologist in the visit?’ | 〇 | ||||||
| Caregiver’s evaluation of intervention in the IG | ‘Did you understand how to use the QPL and did you actually use it?’ ‘Do you think you will continue the intervention?’ ‘Was the intervention useful to you?’ ‘Did the oncologist talk about the QPL?’ ‘Did the QPL help you ask the oncologist questions?’ ‘Is the QPL useful?’ ‘Did you read the QPL before the visit?’ ‘Do you think you will read the QPL in the future?’ | 〇 | ||||||
| Patient’s comprehensive end-of-life QoL | Short version of GDI | 〇 | ||||||
| Oncologist | Oncologist’s patient-centred communication behaviours | SHARE-RE | 〇 | 〇 | ||||
| Oncologist’s patient-preferred communication behaviour | SHARE-total | 〇 | 〇 | |||||
| Oncologist’s patient-preferred communication behaviour | RIAS | 〇 | 〇 | |||||
| Oncologist’s sociological background | Sex, age, clinical experience | 〇 | ||||||
| Oncologist’s evaluation of medical utilisation by patient | The date of management | 〇 | 〇 | |||||
| Oncologist’s evaluation of intervention | The usefulness of intervention | 〇 | ||||||
CoQoLo, Comprehensive Quality of Life Outcome inventory; CSQ, Client Satisfaction Questionnaire; EQ-5D, 5 Dimension EuroQol; FACT-Physical and Functional, Physical Well-being and Functional Well-being subscales of the Functional Assessment of Cancer Therapy; GDI, Good Death Inventory; HADS, Hospital Anxiety and Depression Scale; IG, intervention group; K6, K6 Non-specific Psychological Distress Scale; PEACE, Peace, Equanimity and Acceptance in the Cancer Experience Questionnaire; PTPQ, Prognosis and Treatment Perceptions Questionnaire; QoL, quality of life; QPL, question prompt list; RIAS, Roter Intention Analysis System; SHARE, setting, how to deliver the bad news, additional information, and reassurance and emotional support; TiOS, Trust in Oncologists Scale.